XTANT MEDICAL HOLDINGS INC (XTNT) Forecast, Price Target & Analyst Ratings

NYSEARCA:XTNT • US98420P3082

Current stock price

0.5495 USD
+0.03 (+5.01%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XTANT MEDICAL HOLDINGS INC (XTNT).

Forecast Snapshot

Consensus Price Target

Price Target
$1.26
+ 128.93% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 10, 2026
Period
Q1 / 2026
EPS Estimate
-$0.02
Revenue Estimate
20.568M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.26
Upside
+ 128.93%
From current price of $0.55 to mean target of $1.26, Based on 8 analyst forecasts
Low
$1.01
Median
$1.22
High
$1.58

Price Target Revisions

1 Month
-26.67%
3 Months
-26.67%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for XTNT. The average price target is 1.26 USD. This implies a price increase of 128.93% is expected in the next year compared to the current price of 0.5495.
The average price target has been revised downward by 26.67% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XTNT Current Analyst RatingXTNT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

XTNT Historical Analyst RatingsXTNT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
XTNT was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about XTNT.
In the previous month the buy percentage consensus was at a similar level.
XTNT was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-31BTIGMaintains Buy -> Buy
2025-11-11BTIGMaintains Buy -> Buy
2024-05-16BTIGMaintains Buy -> Buy
2023-12-05BTIGInitiate Buy
2023-07-11Craig-HallumMaintains Buy -> Buy
2023-04-26Craig-HallumInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 10, 2026
Period
Q1 / 2026
EPS Estimate
-$0.02
Revenue Estimate
20.568M
Revenue Q2Q
-37.49%
EPS Q2Q
N/A
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
-19.12%
Revenue (3 Months)
-22.81%
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

XTNT is expected to report earnings on 8/10/2026. The consensus EPS estimate for the next earnings is -0.02 USD and the consensus revenue estimate is 20.57M USD.
The next earnings revenue estimate has been revised downward by 22.81% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
XTNT revenue by date.XTNT revenue by date.
91.303M
57.50%		117.267M
28.44%		133.927M
14.21%		98.124M
-26.73%		107.25M
9.30%		117.4M
9.46%
EBITDA
YoY % growth
XTNT ebitda by date.XTNT ebitda by date.
-6.984M
-27.84%		-7.85M
-12.40%		12.507M
259.32%		2.601M
-79.20%		6.426M
147.06%		8.517M
32.54%
EBIT
YoY % growth
XTNT ebit by date.XTNT ebit by date.
-10.158M
-50.38%		-12.074M
-18.86%		7.284M
160.33%		3.417M
-53.09%		6.681M
95.52%		N/A
Operating Margin
XTNT operating margin by date.XTNT operating margin by date.
-11.13%-10.30%5.44%3.48%6.23%N/A
EPS
YoY % growth
XTNT eps by date.XTNT eps by date.
0.00-0.12
-1,729,382,256,910,270,500.00%		0.03
125.00%		-0.03
-202.00%		-0.01
83.33%		0.01
300.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.02-0.01
-125.50%		-0.01
-202.00%		-0.01-0.01
70.01%		-0.010.00
100.00%		0.00
100.00%		-0.01
-100.00%		0.00
100.00%		0.000.00
Revenue
Q2Q % growth		20.568M
-37.49%		25.041M
-29.28%		24.48M
-26.39%		26.112M
-5.77%		25.5M
23.98%		27.744M
10.79%		26.01M
6.25%		28.101M
7.62%		26.214M
2.80%		29.376M
5.88%		28.152M
8.24%		29.886M
6.35%
EBITDA
Q2Q % growth		196.177K
-90.82%		612K
-91.09%		561K
-90.56%		918K
-78.55%		1.122M
471.93%		1.581M
158.33%		1.683M
200.00%		2.04M
122.22%		1.428M
27.27%		1.938M
22.58%		2.04M
21.21%		2.754M
35.00%
EBIT
Q2Q % growth		-1.412M
-232.80%		-867K
-118.75%		-816K
-132.11%		-510K
45.97%		-255K
81.94%		204K
123.53%		306K
137.50%		714K
240.00%		-510K
-100.00%		N/A102K
-66.67%		918K
28.57%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XTNT Yearly Revenue VS EstimatesXTNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
XTNT Yearly EPS VS EstimatesXTNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2023 2024 2025 2026 2027 2028 0 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-30.20%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-4.54%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
1.65%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

XTANT MEDICAL HOLDINGS INC / XTNT Forecast FAQ

Can you provide the average price target for XTANT MEDICAL HOLDINGS INC stock?

8 analysts have analysed XTNT and the average price target is 1.26 USD. This implies a price increase of 128.93% is expected in the next year compared to the current price of 0.5495.

Can you provide the upcoming earnings date for XTANT MEDICAL HOLDINGS INC?

XTANT MEDICAL HOLDINGS INC (XTNT) will report earnings on 2026-08-10.

Can you provide the consensus estimates for XTANT MEDICAL HOLDINGS INC next earnings?

The consensus EPS estimate for the next earnings of XTANT MEDICAL HOLDINGS INC (XTNT) is -0.02 USD and the consensus revenue estimate is 20.57M USD.

What is the number of analysts for XTNT stock?

The number of analysts covering XTANT MEDICAL HOLDINGS INC (XTNT) is 8.